ArticleThe oncologist2026

An increase in splenic volume after first-line immunotherapy is associated with worse PFS in patients with metastatic renal cell carcinoma.

Gregory Palmateer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.